Iannazzo S, Mannucci E, Mantovani L. [Budget impact analysis of empagliflozin for the treatment of type 2 diabetes in Italy]. Farmeconomia. Health Economics and Therapeutic Pathways. 2016;17(1):19-27. https://doi.org/10.7175/fe.v17i1.1238